Sumatriptan Succinate
Product Images NDC 42254-220

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 42254-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imitrex-tablets-chem-struc.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 01)

Imitrex-tablets-chem-struc.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 01)
Chemical structure of Sumatriptan Succinate showing the molecular arrangement of atoms including indole ring and side chains associated with the active ingredient.*
FDA Label Image

Imitrex-tablets-fig1.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 02)

Imitrex-tablets-fig1.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 02)
A line graph showing estimated probability of response over time in minutes from first dose, comparing placebo and Sumatriptan Succinate doses of 25 mg, 50 mg, and 100 mg. The graph illustrates increasing response probabilities over 240 minutes, with higher doses showing greater efficacy than placebo.*
FDA Label Image

Imitrex-tablets-fig2.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 03)

Imitrex-tablets-fig2.jpg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 03)
A line graph depicting the estimated probability of renal or liver reuse over time in hours after the initial dose for different doses of sumatriptan succinate (placebo, 25 mg, 50 mg, and 100 mg). The probability increases over time, with placebo showing the highest curve, followed by 25 mg, 50 mg, and 100 mg doses in descending order.*
FDA Label Image

Sumatriptan Succinate 25mg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 04)

Sumatriptan Succinate 25mg (B56f236d Fbf8 48e3 Ad42 8abe4aafcbfc 04)
Sumatriptan Succinate 25mg tablets label shows the product name, strength, and dosage form, with each tablet containing 25mg Sumatriptan Succinate. The label includes the NDC 42254-220-09 and indicates the manufacturer as Cobalt Pharmaceuticals Inc. It is distributed by Physician Partner, Thousand Oaks, CA. Storage instructions and lot and expiration number placeholders are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.